AstraZeneca’s COVID-19 vaccine candidate begins late-stage U.S. study
AstraZeneca Plc said on Monday it has begun enrolling adults for a U.S.-funded, 30,000-subject late-stage study of its high profile COVID-19 vaccine candidate. Trial participants…
AZD1222